Form 8-K - Current report:
SEC Accession No. 0001213900-25-004301
Filing Date
2025-01-17
Accepted
2025-01-16 18:18:00
Documents
15
Period of Report
2025-01-16
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0227938-8k_pmgc.htm   iXBRL 8-K 43221
2 PRESS RELEASE DATED AS OF JANUARY 16, 2025 ea022793801ex99-1_pmgc.htm EX-99.1 18571
3 UNAUDITED PRO FORMA CONDENSED CONSOLIDATED STATEMENTS OF INCOME FOR THE FISCAL Y ea022793801ex99-2_pmgc.htm EX-99.2 144905
  Complete submission text file 0001213900-25-004301.txt   400077

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE elab-20250116.xsd EX-101.SCH 3027
5 XBRL LABEL FILE elab-20250116_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE elab-20250116_pre.xml EX-101.PRE 22367
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0227938-8k_pmgc_htm.xml XML 3797
Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 18667944940
PMGC Holdings Inc. (Filer) CIK: 0001840563 (see all company filings)

EIN.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41875 | Film No.: 25536619
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)